Boston Scientific Corporation (BSX)
Automate Your Wheel Strategy on BSX
With Tiblio's Option Bot, you can configure your own wheel strategy including BSX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol BSX
- Rev/Share 11.8826
- Book/Share 15.195
- PB 6.9551
- Debt/Equity 0.5271
- CurrentRatio 1.4502
- ROIC 0.0701
- MktCap 154720881000.0
- FreeCF/Share 1.9449
- PFCF 53.8534
- PE 76.0264
- Debt/Assets 0.2917
- DivYield 0
- ROE 0.0956
- Rating B
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 4
- P/B Score 1
- D/E Score 2
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | BSX | Leerink Partners | -- | Outperform | -- | $118 | June 16, 2025 |
| Upgrade | BSX | Needham | Hold | Buy | -- | $113 | April 16, 2025 |
| Upgrade | BSX | Deutsche Bank | Hold | Buy | -- | $108 | Jan. 10, 2025 |
| Downgrade | BSX | Needham | Buy | Hold | -- | -- | Oct. 18, 2024 |
News
BSX vs. MDT: Which MedSurg Stock Is the Better Investment Now?
Published: June 26, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors are increasingly eyeing the fast-growing MedSurg equipment space, which is projected to witness a compound annual growth rate (CAGR) of 9.54% from 2025 to 2030 (per Grand View Research). Two prominent companies with a strong foothold in this space are Boston Scientific BSX and Medtronic MDT.
Read More
Brokers Suggest Investing in Boston Scientific (BSX): Read This Before Placing a Bet
Published: June 24, 2025 by: Zacks Investment Research
Sentiment: Neutral
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Read More
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Published: June 24, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Read More
BSX Raises 2025 Financial Outlook: What's Backing It?
Published: June 24, 2025 by: Zacks Investment Research
Sentiment: Positive
Boston Scientific lifts its 2025 sales and EPS outlook after a strong Q1, with cardiology and EP segments fueling major gains.
Read More
BSX's Neuromodulation Arm Sees Growth: Q1 Highlights
Published: June 18, 2025 by: Zacks Investment Research
Sentiment: Positive
Boston Scientific's Neuromodulation unit witnesses 6.8% growth in the first quarter, fueled by strong gains in pain and brain therapy lines.
Read More
ISRG vs BSX: Which Medical Device Stock Has More Room to Run?
Published: June 18, 2025 by: Zacks Investment Research
Sentiment: Positive
Boston Scientific offers steady growth with broader exposure, while Intuitive Surgical leads in robotics but faces margin and tariff headwinds.
Read More
What's Happening With Boston Scientific Stock?
Published: June 16, 2025 by: Forbes
Sentiment: Positive
Boston Scientific (NYSE:BSX) has experienced a stock price increase of over 30% in the last twelve months, greatly exceeding the S&P 500's gain of 9%. This remarkable performance can be credited to the launch of new products, which have enhanced sales growth and widened profit margins.
Read More
PAHC vs. BSX: Which Stock Should Value Investors Buy Now?
Published: June 13, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors interested in Medical - Products stocks are likely familiar with Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two stocks is more attractive to value investors?
Read More
BSX Q1 Endoscopy Sales Rise 6%: What's Behind the Growth?
Published: June 13, 2025 by: Zacks Investment Research
Sentiment: Neutral
Boston Scientific's Q1 2025 Endoscopy sales jump 6%, powered by innovation in stents, clips and surgical tools for GI care.
Read More
Cardiovascular Tailwind Boosts BSX: Here's How to Play the Stock
Published: June 10, 2025 by: Zacks Investment Research
Sentiment: Positive
Boston Scientific BSX, a prominent global player in cardiovascular technology, is well-positioned to capitalize on the robust expansion of the cardiovascular devices market. According to a MarketsandMarkets report, this market was valued at $72.83 billion in 2023 and is expected to witness a strong CAGR of 7.3% between 2024 and 2029.
Read More
Boston Scientific (BSX) Upgraded to Buy: Here's Why
Published: June 06, 2025 by: Zacks Investment Research
Sentiment: Positive
Boston Scientific (BSX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Read More
Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year?
Published: June 06, 2025 by: Zacks Investment Research
Sentiment: Positive
Here is how Boston Scientific (BSX) and Dare Bioscience, Inc. (DARE) have performed compared to their sector so far this year.
Read More
Wall Street Bulls Look Optimistic About Boston Scientific (BSX): Should You Buy?
Published: June 06, 2025 by: Zacks Investment Research
Sentiment: Neutral
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Read More
Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors
Published: June 04, 2025 by: Zacks Investment Research
Sentiment: Neutral
In the most recent trading session, Boston Scientific (BSX) closed at $102.43, indicating a -0.65% shift from the previous trading day.
Read More
Profit From the Silver Tsunami: Must-Watch Senior Care & Aging Stocks
Published: June 04, 2025 by: Zacks Investment Research
Sentiment: Positive
BSX, ABBV, AMGN and DXCM are tapping into the aging boom with cutting-edge tech, chronic care drugs and senior-focused innovations.
Read More
Here's Why Boston Scientific (BSX) is a Strong Growth Stock
Published: June 04, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Emerging Markets Power Boston Scientific: Will the Growth Trend Continue?
Published: June 04, 2025 by: Zacks Investment Research
Sentiment: Positive
BSX posts solid Q1 sales growth in emerging markets, reinforcing their role in the company's long-term global strategy.
Read More
Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors
Published: May 29, 2025 by: Zacks Investment Research
Sentiment: Neutral
In the latest trading session, Boston Scientific (BSX) closed at $104.50, marking a -0.01% move from the previous day.
Read More
Boston Scientific Scraps This Aortic Valve, Sticks To 2025 Outlook
Published: May 28, 2025 by: Benzinga
Sentiment: Negative
Boston Scientific Corporation BSX is pulling the plug on its ACURATE neo2 and Prime aortic valve systems.
Read More
PAHC or BSX: Which Is the Better Value Stock Right Now?
Published: May 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two companies is the best option for those looking for undervalued stocks?
Read More
Boston Scientific Corporation (BSX) Bernstein 41st Annual Strategic Decisions Conference (Transcript)
Published: May 28, 2025 by: Seeking Alpha
Sentiment: Neutral
Boston Scientific Corporation (NYSE:BSX ) Bernstein 41st Annual Strategic Decisions Conference Call May 28, 2025 8:01 AM ET Company Participants Michael Mahoney - Chairman and Chief Executive Officer Kenneth Stein - Senior Vice President and Global Chief Medical Officer Conference Call Participants Lee Hambright - Sanford C. Bernstein & Co., LLC Lee Hambright Okay.
Read More
Boston Scientific (BSX) Up 3.3% Since Last Earnings Report: Can It Continue?
Published: May 23, 2025 by: Zacks Investment Research
Sentiment: Positive
Boston Scientific (BSX) reported earnings 30 days ago. What's next for the stock?
Read More
Boston Scientific Corporation (BSX) Bank of America's 2025 Health Care Conference (Transcript)
Published: May 13, 2025 by: Seeking Alpha
Sentiment: Neutral
Boston Scientific Corporation (NYSE:BSX ) Bank of America's 2025 Health Care Conference May 13, 2025 11:00 AM ET Company Participants Daniel Brennan - EVP & CFO Joe Fitzgerald - EVP & Group President, Cardiology Conference Call Participants Travis Steed - Bank of America Travis Steed All right. Good morning, everybody.
Read More
PAHC or BSX: Which Is the Better Value Stock Right Now?
Published: May 12, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors interested in Medical - Products stocks are likely familiar with Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two companies is the best option for those looking for undervalued stocks?
Read More
Here is What to Know Beyond Why Boston Scientific Corporation (BSX) is a Trending Stock
Published: May 08, 2025 by: Zacks Investment Research
Sentiment: Positive
Zacks.com users have recently been watching Boston Scientific (BSX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Read More
Earnings Season: 3 Companies Raising Guidance
Published: April 29, 2025 by: Zacks Investment Research
Sentiment: Positive
Raising guidance? In this uncertainty?
Read More
Baron Health Care Fund Q1 2025 Top Contributors And Detractors
Published: April 29, 2025 by: Seeking Alpha
Sentiment: Positive
Boston Scientific's shares rose due to strong market growth, innovative products like pulsed field ablation, and disciplined cost management, driving double-digit EPS growth. Vertex Pharmaceuticals saw increased investor confidence in its cystic fibrosis franchise and evolving pipeline, including promising non-opioid pain treatments and kidney disease drugs. UnitedHealth Group's shares gained as 2024 headwinds subsided, Medicare Advantage rates improved, and higher-margin Optum segments grew, insulating it from tariff impacts.
Read More
EMEA Growth & Product Launches to Support Boston Scientific Stock
Published: April 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Boston Scientific successfully continues with its expansion of operations across different geographies outside the United States.
Read More
Here is Why Growth Investors Should Buy Boston Scientific (BSX) Now
Published: April 25, 2025 by: Zacks Investment Research
Sentiment: Positive
Boston Scientific (BSX) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Read More
Boston Scientific (BSX) Upgraded to Buy: Here's What You Should Know
Published: April 25, 2025 by: Zacks Investment Research
Sentiment: Positive
Boston Scientific (BSX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Read More
About Boston Scientific Corporation (BSX)
- IPO Date 1992-05-19
- Website https://www.bostonscientific.com
- Industry Medical - Devices
- CEO Michael F. Mahoney
- Employees 53000